Description
Concentration – 10 mg per vial
Physical Form – Lyophilized powder (sterile 3 mL vial)
Product Features
-
Freeze-dried for maximal shelf stability
-
Butyl rubber stopper allows multiple punctures while maintaining a secure seal
-
Vials are depyrogenated, ETO-sterilized, and finished with a tamper-evident aluminum flip-top
Research Highlights
-
Triple Agonist Mechanism: Retatrutide is an investigational peptide activating GLP-1, GIP, and glucagon receptors, producing synergistic effects on metabolism in preclinical studies.
-
Weight Management: Demonstrated substantial body weight reductions, enhanced insulin sensitivity, and improved lipid profiles in animal models.
-
Glycemic Control: Combined incretin and glucagon receptor activation aids glucose regulation while maintaining lean muscle mass.
-
Metabolic Flexibility: Research indicates improvements in mitochondrial efficiency, fatty acid oxidation, and resting energy expenditure.
-
Emerging Applications: Under investigation for obesity, type 2 diabetes, and prevention of cardiometabolic disorders.


Reviews
There are no reviews yet.